Bausch Health Companies Inc.

BHC · NYSE · SIC 2834: Pharmaceutical Preparations
256
SEC Filings

Business Summary

PART I Introduction Bausch Health Companies Inc. (we, us, our, the Company or Bausch Health) is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and aesthetic medical devices and, through our approximately 88% ownership of Bausch +...

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBHCdiscussed_in_filing Cybersecurity
topic_mentionBHCdiscussed_in_filing Blockchain & Crypto
topic_mentionBHCdiscussed_in_filing Cybersecurity
topic_mentionBHCdiscussed_in_filing Blockchain & Crypto
topic_mentionBHCdiscussed_in_filing Blockchain & Crypto
topic_mentionBHCdiscussed_in_filing Healthcare & Bio
topic_mentionBHCdiscussed_in_filing Blockchain & Crypto
topic_mentionBHCdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310000885590-26-000023EDGAR134K words
2025-02-202024-12-310000885590-25-000007EDGAR—
2024-02-222023-12-310000885590-24-000011EDGAR—
2023-02-232022-12-310000885590-23-000009EDGAR—
2022-02-232021-12-310000885590-22-000010EDGAR—
2021-02-242020-12-310000885590-21-000011EDGAR—
2020-02-192019-12-310000885590-20-000006EDGAR—
2019-02-202018-12-310000885590-19-000006EDGAR—
2018-02-282017-12-310000885590-18-000017EDGAR—
2017-03-012016-12-310000885590-17-000015EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300000885590-25-000051EDGAR65K words
2025-07-312025-06-300000885590-25-000032EDGAR—
2025-05-012025-03-310000885590-25-000020EDGAR—
2024-10-312024-09-300000885590-24-000036EDGAR—
2024-08-012024-06-300000885590-24-000029EDGAR—
2024-05-022024-03-310000885590-24-000019EDGAR—
2023-11-022023-09-300000885590-23-000035EDGAR—
2023-08-032023-06-300000885590-23-000028EDGAR—
2023-05-042023-03-310000885590-23-000018EDGAR—
2022-11-032022-09-300000885590-22-000061EDGAR—
2022-08-092022-06-300000885590-22-000039EDGAR—
2022-05-102022-03-310000885590-22-000025EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001193125-26-085755EDGAR1K words
2026-02-180000885590-26-000020EDGAR—
2026-01-230000885590-26-000008EDGAR—
2026-01-130000885590-26-000005EDGAR—
2026-01-020000950103-26-000052EDGAR—
2025-12-290000885590-25-000059EDGAR—
2025-12-230000885590-25-000057EDGAR—
2025-12-120000950103-25-016089EDGAR—
2025-12-090000885590-25-000054EDGAR—
2025-11-240001193125-25-291998EDGAR—

256 total filings indexed. 224 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000885590
TickerBHC
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedNJ

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a86b6063d38e40327fb9e2d4e458313312b69800918bc728757753dfbce43c0c
parent: c38fb0dffc1d682d9b00518bc3b3f46c25a6f3a55294d2dd0aae2342f3729913
content hash: da36197be5abd83b1ffd66ecd33b658d8b2552efaae05e78a2f02dd0b06c65e3
signed: 2026-04-13T04:43:57.414Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf